Tag Archives: Pandemic

U.S. job openings fall in November; layoffs rise

WASHINGTON (Reuters) – U.S. job openings fell in November, while layoffs mounted at restaurants and hotels amid rampant COVID-19 infections, supporting views that the labor market recovery from the pandemic was stalling.

Job openings, a measure of labor demand, dropped 105,000 to 6.527 million on the last day of November, the Labor Department said on Tuesday in its monthly Job Openings and Labor Turnover Survey, or JOLTS. Vacancies have dropped from as high as 7.012 million in January.

The job openings rate slipped to 4.4% from 4.5% in October. Layoffs increased 295,000 to nearly 2.0 million. That lifted the layoffs rate to 1.4% from 1.2% in October. Layoffs were led by the accommodation and food services industry, which shed 263,000 workers. A resurgence in coronavirus cases has led to widespread curbs on businesses, with restaurants and bars hardest hit.

There were 42,000 job losses in the healthcare and social assistance sector. State and local governments, which are experiencing tight budgets because of the pandemic, laid off 21,000 workers.

Hiring was little changed at 5.979 million. The hiring rate was steady at 4.2%.

The JOLTS report followed on the heels of news last Friday that the economy shed 140,000 jobs in December, the first decline in nonfarm payrolls since April, after adding 336,000 positions in November. The economy has recovered 12.4 million of the 22.2 million jobs lost in March and April.

(Reporting By Lucia Mutikani; Editing by Andrea Ricci)

China says WHO team to probe COVID-19 origins will arrive Thursday

BEIJING/GENEVA (Reuters) – A World Health Organization (WHO) team of international experts tasked with investigating the origins of the COVID-19 pandemic will arrive in China on Jan. 14, Chinese authorities said on Monday.

Lack of authorization from Beijing had delayed the arrival of the 10-strong team on a long-awaited mission to investigate early infections, in what China’s foreign ministry called a “misunderstanding”.

The National Health Commission, which announced the arrival date, delayed from its early January schedule, did not detail the team’s itinerary, however.

WHO chief Tedros Adhanom Ghebreyesus welcomed the news and said that studies would begin in the central city of Wuhan where the first human cases were identified.

“We look forward to working closely with our (Chinese) counterparts on this critical mission to identify the virus source & its route of introduction to the human population,” Tedros wrote on Twitter. He previously said he was “very disappointed” when experts were denied entry earlier this month, forcing two members of the team to turn back.

China has been accused of a cover-up that delayed its initial response, allowing the virus to spread since it first emerged in the central city of Wuhan late in 2019.

The United States has called for a “transparent” WHO-led investigation and criticized its terms, which allowed Chinese scientists to do the first phase of preliminary research.

Ahead of the trip, Beijing has been seeking to shape the narrative about when and where the pandemic began, with senior diplomat Wang Yi saying “more and more studies” showed it emerged in multiple regions.

A health expert affiliated with the WHO said expectations should be “very low” that the team will reach a conclusion from their trip to China.

WHO emergencies chief Mike Ryan sought to defuse tensions around the trip at a virtual press briefing later on Monday.

“We are looking for the answers here that may save us in future – not culprits and not people to blame,” he said, adding that the WHO was willing to go “anywhere and everywhere” to find out how the virus emerged.

While other countries continue to struggle with infection surges, China has aggressively doused flare-ups.

Sunday’s 103 new cases were mainland China’s biggest daily increase in more than five months, as new infections rise in the province of Hebei, surrounding the capital, Beijing.

Shijiazhuang, capital of Hebei, went into lockdown and Hebei closed down some sections of highways in the province to curb the spread of the virus.

(Reporting by Gabriel Crossley and Emma Farge and Stephanie Nebehay in Geneva; Writing by Se Young Lee; Editing by Clarence Fernandez, Michael Perry and Toby Chopra)

PM Johnson says UK in ‘race against time’ as it faces worst weeks of pandemic

By Michael Holden

LONDON (Reuters) – Prime Minister Boris Johnson said on Monday Britain was in “a race against time” to roll out COVID-19 vaccines as deaths hit record highs and hospitals ran out of oxygen, and his top medical adviser said the pandemic’s worst weeks were imminent.

A new, more transmissible variant of the disease is now surging through the population, with one in 20 people in parts of London now infected, threatening to overwhelm the National Health Service (NHS) as hospitals fill up with patients.

The death toll in the United Kingdom has been soaring and now stands in excess of 81,000 – the world’s fifth-highest official toll – while more than three million people have tested positive.

In a bid to get on top of the pandemic and to try to restore some degree of normality by the spring, Britain is rushing out its largest ever vaccination program, with shots to be offered to about 15 million people by the middle of next month.

“It’s a race against time because we can all see the threat that our NHS faces, the pressure it’s under, the demand in intensive care units, the pressure on ventilated beds, even the shortage of oxygen in some places,” Johnson said on a visit to a vaccination center in Bristol, in southwest England.

“This is a very perilous moment. The worst thing now for us is to allow success in rolling out a vaccine program to breed any kind of complacency about the state of the pandemic.”

The government’s chief medical adviser Chris Whitty earlier said the situation was set to deteriorate.

“The next few weeks are going to be the worst weeks of this pandemic in terms of numbers into the NHS,” he told BBC TV.

“Anybody who is not shocked by the number of people in hospital who are seriously ill at the moment and who are dying over the course of this pandemic, I think, has not understood this at all. This is an appalling situation,” he told BBC TV.

VACCINATION TARGET

Health minister Matt Hancock said there were now more than 32,000 COVID-19 patients in hospital, far more than the roughly 18,000 hospitalized during the peak of the first wave of the pandemic in April.

Johnson’s government is pinning its hopes on a mass vaccination program after Britain became the first country to approve vaccines developed by Oxford-AstraZeneca and by Pfizer/BioNTech. It also approved Moderna’s shot last Friday.

Its plan, announced on Monday, envisages two million shots being delivered to around 2,700 centers a week in England by the end of January, with the aim of immunizing tens of millions of people by the spring and all adults offered a vaccine by the autumn.

The first daily vaccination statistics showed that nearly 2.3 million people had so far received their first doses of a COVID vaccine and nearly 400,000 had received a second dose.

Johnson said more had received the vaccine in Britain than in any other European country but admitted that inoculating 15 million people in the four highest risk levels, including those over 70 and frontline health workers, by a Feb. 15 target was “a huge ask”.

“We believe it’s achievable, we’re going throw absolutely everything at it, to get it done,” he said.

Opposition Labor leader Keir Starmer, who has repeatedly accused Johnson of being too slow to respond to the pandemic, said the prime minister’s indecision had cost lives and worsened the economic impact

Ministers and health chiefs have pleaded with Britons to stay at home, amid fears that some people are not adhering to the rules strictly enough, along with concern that the virus is being spread in supermarkets.

Hancock said that support bubbles, where households can “bubble” with another if they are single-person or fit other criteria, would be maintained, but that rules on exercising with someone else could be restricted.

“Where we have to tighten them, we will,” Johnson said of the rules.

(Additional reporting by Guy Faulconbridge, Kate Holton, William Schomberg, Paul Sandle, Alistair Smout and James Davey; writing by Michael Holden; editing by Estelle Shirbon, Guy Faulconbridge, Angus MacSwan and Gareth Jones)

Germany introduces tougher restrictions in pandemic battle

By Andreas Rinke and Holger Hansen

BERLIN (Reuters) – Germany is extending its nationwide lockdown until the end of the month and introducing tougher new restrictions in an effort to curb surging coronavirus infections, Chancellor Angela Merkel said on Tuesday.

“We need to restrict contact more strictly… We ask all citizens to restrict contact to the absolute minimum,” Merkel told reporters after a meeting with the leaders of Germany’s 16 federal states.

The new rules restrict for the first time non-essential travel for residents of hard-hit areas all over Germany.

They limit movement to a 15-kilometre (nine-mile) radius in towns and districts where the number of new coronavirus cases is above 200 per 100,000 residents over seven days.

Members of any one household will be allowed to meet only one other person in public. That compares with a current rule under which public gatherings are limited to five people from two households.

Like many other European countries, Germany is struggling to contain a second wave of the virus. Britain began its third COVID-19 lockdown on Tuesday with citizens under orders to stay at home.

Concern is growing that hospitals in Germany will struggle to cope, and Merkel said a new mutation of the coronavirus first detected in Britain increased the need to be more cautious.

SHOPS, SCHOOLS TO STAY SHUT

Shops and restaurants will remain shut until the end of January. Schools are also to remain closed, with classes to be held online, until at least the end of the month.

“We believe these measures are justified, even if they are hard,” Merkel said.

The chancellor said she and the state leaders would review the new measures on Jan. 25.

The number of confirmed coronavirus cases in Germany rose by 11,897 to 1.787 million in the last day, the Robert Koch Institute for infectious diseases said on Tuesday. The death toll rose by 944 to 35,518.

Germany had imposed a partial lockdown in November but was forced to close schools, shops and restaurants in mid-December after the initial steps failed to have the desired impact.

Germany is rolling out a vaccine against COVID-19 but the media and some officials have criticized the government for a slow start and for ordering too few doses. By Tuesday, around 317,000 people had received a shot.

(Additional reporting by Madeline Chambers, Joseph Nasr and Sabine Siebold; writing by Madeline Chambers and Maria Sheahan, Editing by Alexandra Hudson and Gareth Jones)

U.S. factory activity near 2-1/2-year high; COVID-19 disrupting supply chains

By Lucia Mutikani

WASHINGTON (Reuters) -U.S. factory activity accelerated to its highest level in nearly 2-1/2 years in December as the coronavirus pandemic continues to pull demand away from services towards goods, though spiraling new infections are causing bottlenecks in supply chains.

The strength in manufacturing reported by the Institute for Supply Management (ISM) on Tuesday likely helped to soften the blow on the economy in the fourth quarter from the relentless spread of COVID-19 and government delays in approving another rescue package to help businesses and the unemployed.

The ISM said the virus was “limiting manufacturing growth potential” because of absenteeism and short-term shutdowns to sanitize facilities at factories and their suppliers.

“U.S. manufacturing should fare reasonably well this winter as businesses need to restock inventories and the shift in consumer spending away from services to goods helps manufacturers,” said Ryan Sweet, a senior economist at Moody’s Analytics in West Chester, Pennsylvania.

The ISM’s index of national factory activity rebounded to a reading of 60.7 last month. That was the highest level since August 2018 and followed a reading of 57.5 in November. A reading above 50 indicates expansion in manufacturing, which accounts for 11.9% of the U.S. economy. Economists polled by Reuters had forecast the index would slip to 56.6 in December.

But some of the surprise rebound in the ISM index was due to an increase in the survey’s measure of supplier deliveries to a reading of 67.6 last month from 61.7 in November.

A lengthening in suppliers’ delivery times is normally associated with a strong economy and increased customer demand, which would be a positive contribution. But in this case slower supplier deliveries also indicate supply shortages related to the pandemic.

Nevertheless, demand for manufactured goods has been strong as the resurgence in new COVID-19 cases has led to fresh business restrictions across the United States, largely impacting the vast services sector.

A large section of the population continues to work and take classes at home, fueling a scramble for electronics, home improvement products and other goods like exercise equipment.

Computer and electronic products manufacturers said they continued to have “tailwinds from the COVID-19 pandemic research support for vaccines and treatments,” adding that “business picked up for us in the last month.”

Makers of miscellaneous products said “sales are now exceeding pre-COVID-19 levels.” Electrical equipment, appliances and components producers reported that business was stronger than expected, “with higher demand for many products.”

Despite strong demand, manufacturing output is still about 3.8% below its pre-pandemic level, according to the Federal Reserve. That could persist for a while as the new wave of infections causes disruptions to labor and the supply chain.

Food manufacturers complained the virus was “affecting us more strongly now than back in March.” Similar sentiments were echoed by transportation equipment makers who said the outbreaks were constraining suppliers. Plastics and rubber products also reported that their suppliers were having difficulty finding and retaining labor.

STRONG ORDERS GROWTH

The ISM report followed on the heels of data on Monday showing strong construction spending in November and October. Strength in the two sectors supports economists’ predictions that the economy grew at around a 5% annualized rate in the fourth quarter after a record 33.4% pace in the third quarter.

The manufacturing boost to gross domestic product would come through an accumulation of inventory by businesses.

The virus and depleted government pandemic money took a bite out of consumer spending in November. More than $3 trillion in government pandemic relief fueled growth in the July-September quarter after the economy contracted at a historic 31.4% rate in the second quarter. Nearly $900 billion in fiscal stimulus was approved in late December.

The ISM’s forward-looking new orders sub-index rose to a reading of 67.9 last month from 65.1 in November. Strong orders growth boosted manufacturing employment, which had contracted in November. The ISM’s manufacturing employment gauge rebounded to 51.5 from a reading of 48.4 in November.

But the supply chain gridlock is driving up costs for manufacturers. The survey’s prices paid index jumped to a reading of 77.6 last month, the highest since May 2018, from 65.4 in November. That raises the risk of higher inflation this year, though high unemployment could limit price pressures.

The labor market has lost steam in tandem with the economy since job growth peaked at a record 4.781 million in June.

According to an early Reuters survey of economists, nonfarm payrolls probably increased by 100,000 jobs last month after rising by 245,000 in November. That would mean the economy recouped about 12.5 million of the 22.2 million jobs lost in March and April. The government is scheduled to publish December’s employment report on Friday.

(Reporting by Lucia MutikaniEditing by Chizu Nomiyama and Paul Simao)

China doubles down on COVID narrative as WHO investigation looms

By David Stanway

SHANGHAI (Reuters) – As a team from the World Health Organization (WHO) prepares to visit China to investigate the origins of COVID-19, Beijing has stepped up efforts not only to prevent new outbreaks, but also shape the narrative about when and where the pandemic began.

China has dismissed criticism of its early handling of the coronavirus, first identified in the city of Wuhan at the end of 2019, and foreign ministry spokeswoman Hua Chunying said on Monday that the country would welcome the WHO team.

But amid simmering geopolitical tensions, experts said the investigators were unlikely to be allowed to scrutinize some of the more sensitive aspects of the outbreak, with Beijing desperate to avoid blame for a virus that has killed more than 1.8 million people worldwide.

“Even before this investigation, top officials from both sides have been very polarized in their opinions on the origins of the outbreak,” said Yanzhong Huang, senior fellow with the Council on Foreign Relations, a U.S. think tank.

“They will have to be politically savvy and draw conclusions that are acceptable to all the major parties,” he added.

While other countries continue to struggle with infection surges, China has aggressively doused flare-ups. After a new cluster of cases last week, the city of Shenyang sealed off entire communities and required all non-essential workers to stay home.

On Saturday, senior diplomat Wang Yi praised the anti-pandemic efforts, saying China not only curbed domestic infections, but also “took the lead in building a global anti-epidemic defense” by providing aid to more than 150 countries.

But mindful of the criticism China has faced worldwide, Wang also became the highest-ranking official to question the consensus about COVID-19’s origins, saying “more and more studies” show that it emerged in multiple regions.

China is also the only country to claim COVID-19 can be transmitted via cold chain imports, with the country blaming new outbreaks in Beijing and Dalian on contaminated shipments – even though the WHO has downplayed those risks.

TRANSPARENCY

China has been accused of a cover-up that delayed its initial response, allowing the virus to spread further.

The topic remains sensitive, with only a handful of studies into the origins of COVID-19 made available to the public.

But there have also been signs China is willing to share information that contradicts the official picture.

Last week, a study by China’s Center for Disease Control showed that blood samples from 4.43% of Wuhan’s population contained COVID-19 antibodies, indicating that the city’s infection rates were far higher than originally acknowledged.

But scientists said China must also share any findings suggesting COVID-19 was circulating domestically long before it was officially identified in December 2019.

An Italian study showed that COVID-19 might have been in Europe several months before China’s first official case. Chinese state media used the paper to support theories that COVID-19 originated overseas and entered China via contaminated frozen food or foreign athletes competing at the World Military Games in Wuhan in October 2019.

Raina MacIntyre, head of the Kirby Institute’s Biosecurity Research Program in Australia, said the investigation needed to draw “a comprehensive global picture of the epidemiological clues”, including any evidence COVID-19 was present outside of China before December 2019.

However, political issues mean they are unlikely to be given much leeway to investigate one hypothesis, that the outbreak was caused by a leak at the Wuhan Institute of Virology, said MacIntyre.

“I think it is unlikely all viruses in the lab at the time will be made available to the team,” she said. “So I do not think we will ever know the truth.”

Pediatric use of COVID-19 antibody drugs not advised by experts; disinfectant use can cause asthma flares

By Nancy Lapid

(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Experts advise against antibody drugs in pediatric COVID-19

As of now, antibody therapies for COVID-19 should not be used to treat infections with the new coronavirus in children or adolescents, “including those … at high risk of progression to hospitalization or severe disease,” according to a panel of experts from 29 hospitals across North America who reviewed the available evidence. The antibody drugs – bamlanivimab from Eli Lilly and Co and the combination of casirivimab plus imdevimab from Regeneron Pharmaceuticals Inc – were authorized in November by the U.S Food and Drug Administration for emergency use in certain groups of adolescents and adults with mild-to-moderate COVID-19. But in a paper published on Sunday in the Journal of the Pediatric Infectious Diseases Society, the panel of experts said: “The course of COVID-19 in children and adolescents is typically mild and there is no high-quality evidence supporting any high risk groups. There is no evidence for safety and efficacy of monoclonal antibody therapy for treatment of COVID-19 in children or adolescents, limited evidence of modest benefit in adults, and evidence for potential harm.” (https://bit.ly/3b2kVyG)

Disinfecting during pandemic puts asthmatics at risk

Increased cleaning by people with asthma during the pandemic may be triggering flares of their disease, a new report suggests. Researchers who surveyed 795 U.S. adults with asthma between May and September found the proportion who disinfected surfaces with bleach at least five times a week rose by 155% after the pandemic started. Use of disinfectant wipes, sprays, and other liquids also increased, the researchers reported in Journal of Allergy & Clinical Immunology: In Practice. After accounting for other behaviors and risk factors, higher odds of having uncontrolled asthma were linked with greater household use of disinfectant wipes, disinfectant sprays, bleach and water solutions, and other disinfecting liquids. The study does not prove that increased frequency of disinfecting caused uncontrolled asthma. Still, the authors say, people with asthma need safer cleaning options. The U.S. Centers for Disease Control and Prevention advises asthmatics to ask someone else to clean and disinfect surfaces and to stay in another room when cleaners or disinfectants are used and right afterward. It also said soap and water may be sufficient for surfaces and objects that are seldom touched.

News reports paint overly rosy picture of blood treatment

News reports about critically ill COVID-19 patients treated with a last-ditch procedure known as extracorporeal membrane oxygenation, or ECMO, may be painting an unrealistic picture of outcomes, a study suggests. During ECMO, blood is pumped outside of the body through a machine that removes carbon dioxide and adds oxygen before returning the blood back to the body. In a review of media reports about ECMO treatment of COVID-19, doctors found that 92% of patients in the stories survived, whereas average survival rates after ECMO in large studies have ranged from 53% in children to 63% in young and middle-aged adults. Patients receiving the ECMO treatment “remain at substantial risk” of complications and death, but most news reports of COVID-19 patients treated with ECMO did not address these risks, the researchers said on Monday in JAMA Internal Medicine. They say recognition of the exaggerated benefit suggested by media reports may help intensive care unit doctors, patients and families have more realistic discussions about prognosis after ECMO.

(Reporting by Nancy Lapid; Editing by Bill Berkrot)

New York, Florida tell hospitals to speed COVID-19 vaccinations or lose supply

By Carl O’Donnell and Jonathan Allen

NEW YORK (Reuters) – The governors of New York and Florida sought to accelerate the slower-than-expected rollout of coronavirus vaccines by warning hospitals on Monday that they would reduce future allocations to those that fail to dispense shots quickly enough.

In New York, hospitals must administer vaccines within a week of receiving them or face a fine and loss of future supplies, Governor Andrew Cuomo said.

“I don’t want the vaccine in a fridge or a freezer, I want it in somebody’s arm,” the governor said. “If you’re not performing this function, it does raise questions about the operating efficiency of the hospital.”

The U.S. federal government has distributed more than 15 million vaccine doses to states and territories around the country, but only around 4.5 million have been administered so far, according to data from the U.S. Centers for Disease Control and Prevention (CDC) released on Monday.

The U.S. government has fallen far short of its target of vaccinating 20 million people by the end of 2020. Officials said they expect the rollout will pick up significantly this month.

Surgeon General Jerome Adams told CBS News that there are 15 million to 20 million doses of vaccine available.

“We should be hopeful about that while acknowledging we have got to do better and we are going to keep doing better,” Adams said. “And I promise you, you will see in these next two weeks numbers increase substantially.”

The United States had reported a total of 20.5 million COVID-19 cases and 351,480 deaths as of midnight on Sunday. On a seven-day rolling average, it is reporting 210,190 cases and 2,636 coronavirus deaths per day.

In Florida, where officials have put senior citizens ahead of many essential workers for getting the vaccine, Governor Ron DeSantis announced a policy under which the state would allocate doses to hospitals that dispense them most quickly,

“Hospitals that do not do a good job of getting the vaccine out will have their allocations transferred to hospitals that are doing a good job at getting the vaccine out,” DeSantis said at a briefing.

“We do not want vaccine to just be idle at some hospital system,” he added, though he did not say they would face fines.

Florida will also deploy an additional 1,000 nurses to administer vaccines and will keep state-run vaccination sites open seven days a week, he said.

New York has dispensed about 175,000 doses of the 896,000 it has received since mid-December, according to CDC data. Florida has dispensed 265,000 of the 1.14 million doses it received.

In New York City, Mayor Bill de Blasio said obstacles were slowing his goal to have 1 million residents receive a first of two vaccine doses by the end of January. A little over 110,000 residents have received their first dose so far, according to city data.

De Blasio urged the state to broaden early eligible groups beyond healthcare workers and nursing home residents to include essential workers such as teachers, police officers, fire fighters, grocery store personnel and people who are more than 75 years old.

New York City currently has 125 vaccination sites and plans to double that by the end of the month, the mayor said.

“This has got to be a seven-day-a-week, 24-hour reality going forward,” de Blasio said.

Monday also marked the first day when some Americans were due to receive their second vaccine shot, three weeks after getting the first dose. Among them was Maritza Beniquez, a healthcare worker in Newark, New Jersey.

“I now have body armor,” she said after receiving the dose in a video posted on Facebook by New Jersey Governor Phil Murphy, who was part of a small gathering that witnessed the event.

(Reporting by Jonathan Allen, Carl O’Donnell, Rebecca Spaulding and Peter Szekely in New York; Additional reporting by Barbara Goldberg, Anurag Maan, Doina Chiacu and Susan Heavey; Editing by Bill Berkrot)

In deadliest week so far, U.S. loses more than 18,400 lives to COVID-19

(Reuters) – December was the deadliest month of the coronavirus pandemic in the United States with nearly 78,000 deaths, and health officials warned that even more people will likely die in January despite the rollout of vaccines.

In the week ended Jan. 3, more than 18,400 people died from COVID-19, bringing the pandemic’s total to over 351,000 deaths, or one in every 930 U.S. residents, according to a Reuters analysis of state and county reports.

The country reported nearly 1.5 million new infections last week, up 16.5% from the previous seven days.

Many testing centers were closed for the year-end holiday, likely reducing the number of cases reported last week. Health officials have warned that figures this week may be abnormally high due to a backlog of data.

More than 126,000 COVID-19 patients are currently in hospitals, up 25% from one month ago. The rise in hospitalizations, which have hit new records almost every day in recent weeks, is the main reason health experts predict further increases in deaths in coming weeks.

Despite pleas to avoid traveling for the holidays, U.S. airports screened 1.3 million people on Sunday, the highest since mid-March.

Arizona, Tennessee and South Carolina reported the most new cases per capita last week, according to the Reuters analysis. In terms of deaths per capita, Kansas, Wyoming and New Mexico were the hardest hit last week.

Across the United States, 13.6% of tests came back positive for the virus, up from 10.3% the prior week, according to data from the volunteer-run COVID Tracking Project. The highest rates were in Iowa at 64%, Idaho at 56% and Alabama at 47%.

The World Health Organization considers positive test rates above 5% concerning because it suggests there are more cases in the community that have not yet been uncovered.

(Graphic by Chris Canipe, writing by Lisa Shumaker, editing by Tiffany Wu)

U.S., EU criticize China for jailing citizen-journalist who reported on COVID-19

BRUSSELS/WASHINGTON (Reuters) – The European Union and United States on Tuesday criticized the jailing of a citizen-journalist in China who reported on the early outbreak of the coronavirus pandemic from Wuhan.

A Chinese court handed down a four-year jail term on Monday to Zhang Zhan, who reported at the peak of the crisis in the city where the coronavirus first emerged. Her lawyer said Zhang was jailed on the grounds of “picking quarrels and provoking trouble”.

U.S. Secretary of State Mike Pompeo said in a statement that he strongly condemned Zhang’s conviction and called for her immediate and unconditional release, accusing the Chinese Communist Party (CCP) of restricting and manipulating information about the COVID-19 outbreak in Wuhan.

“Her hasty trial, to which foreign observers were denied access, shows how fearful the CCP is of Chinese citizens who speak the truth,” Pompeo said, adding that the United States would always support the right of Chinese citizens to express themselves freely.

U.S.-China relations have plunged to their worst level in decades as the world’s top two economies spar over issues ranging from the coronavirus outbreak, Beijing’s national security law for Hong Kong, trade and espionage.

The EU also called for Zhang’s immediate release, as well as for freedom for jailed human rights lawyer Yu Wensheng, and several other detained and convicted human rights defenders and individuals who engaged in reporting in the public interest.

“According to credible sources, Ms. Zhang has been subject to torture and ill-treatment during her detention and her health condition has seriously deteriorated,” an external affairs spokesman for the 27-nation EU said in a statement.

Separately, the EU called on China to “guarantee procedural fairness and due process of law” for 10 Hong Kong activists on trial in China after being caught at sea and accused of trying to flee to Taiwan.

In a statement it called for the immediate release of the group and their swift return to Hong Kong from Shenzhen, where they went on trial on Dec. 28 in a closed court and without appointed lawyers of their choice.

The EU criticism over the cases comes a day before EU and Chinese leaders are expected to clinch a deal to give European companies better access to the Chinese market.

Citizen-journalist Zhang was among a handful of people whose firsthand accounts from crowded hospitals and empty streets painted a more dire picture of the pandemic epicenter than the official narrative.

Critics say that China deliberately arranged for Zhang’s trial to take place during the holiday season in the West, to minimize scrutiny.

“The restrictions on freedom of expression, on access to information, and intimidation and surveillance of journalists, as well as detentions, trials and sentencing of human rights defenders, lawyers, and intellectuals in China, are growing and continue to be a source of great concern,” the EU spokesman said.

(Reporting by John Chalmers in Brussels and Daphne Psaledakis in Washingtond; editing by Jonathan Oatis)